Author:
Su Junhao,Lui Wui Wang,Lee YanLam,Zheng Zhenxian,Siu Gilman Kit-Hang,Ng Timothy Ting-Leung,Zhang Tong,Lam Tommy Tsan-Yuk,Lao Hiu-Yin,Yam Wing-Cheong,Tam Kingsley King-Gee,Leung Kenneth Siu-Sing,Lam Tak-Wah,Leung Amy Wing-Sze,Luo Ruibang
Abstract
AbstractSensitive detection of Mycobacterium tuberculosis (TB) in small percentages in metagenomic samples is essential for microbial classification and drug resistance prediction. However, traditional methods, such as bacterial culture and microscopy, are time-consuming and sometimes have limited TB detection sensitivity. Oxford nanopore technologies (ONT) MinION sequencing allows rapid and simple sample preparation for sequencing. Its recently developed adaptive sequencing selects reads from targets while allowing real-time base-calling to achieve sequence enrichment or depletion during sequencing. Another common enrichment method is PCR amplification of the target TB genes. In this study, we compared both methods using ONT MinION sequencing for TB detection and variant calling in metagenomic samples using both simulation runs and those with synthetic and patient samples. We found that both methods effectively enrich TB reads from a high percentage of human (95%) and other microbial DNA. Adaptive sequencing with readfish and UNCALLDE achieved a 3.9-fold and 2.2-fold enrichment compared to the control run. We provide a simple automatic analysis framework to support the detection of TB for clinical use, openly available at https://github.com/HKU-BAL/ONT-TB-NF. Depending on the patient's medical condition and sample type, we recommend users evaluate and optimize their workflow for different clinical specimens to improve the detection limit.
Funder
General Research Fund
Hong Kong Research Grants Council grant TRS
AIR@InnoHK funding (D24H) administered by Innovation and Technology Commission of Hong Kong Special Administrative Region
ECS
TRS
URC fund at HKU
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Zhou, X. et al. Clinical evaluation of diagnosis efficacy of active mycobacterium tuberculosis complex infection via metagenomic next-generation sequencing of direct clinical samples. Front. Cell. Infect. Microbiol. 9, 351 (2019).
2. Falzon, D. et al. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update. Eur. Respir. J. 49, 3 (2017).
3. Warren, R. et al. Differentiation of Mycobacterium tuberculosis complex by PCR amplification of genomic regions of difference. Int. J. Tuberc. Lung Dis. 10, 818–822 (2006).
4. Khan, Z. A., Siddiqui, M. F. & Park, S. Current and emerging methods of antibiotic susceptibility testing. Diagnostics 9, 49 (2019).
5. Georghiou, S. B. et al. Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: Implications for diagnosis and treatment. Eur. Respir. J. 59, 2200166. https://doi.org/10.1183/13993003.00166-2022 (2022).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献